Del Valle G O, Adair C D, Sanchez-Ramos L, Gaudier F L, McDyer D C, Delke I
Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville 32209-6511.
Int J Gynaecol Obstet. 1994 Oct;47(1):17-21. doi: 10.1016/0020-7292(94)90455-3.
To evaluate the safety and efficacy of preinduction cervical ripening in women with previous cesarean deliveries undergoing induction of labor.
Retrospective study of women with previous low transverse cesarean deliveries who underwent ripening of an unfavorable cervix prior to induction of labor (n = 89). Multiparas without previous cesarean deliveries undergoing ripening and induction of labor during the same time period were used for comparison (n = 61). Ripening was performed with prostaglandin E2 (PGE2) gel, or an osmotic dilator, or both. Induction of labor with oxytocin followed the American College of Obstetricians and Gynecologists' guidelines. Outcome data were analyzed using the unpaired Student's t-test or chi 2-test as appropriate. Significance was established at P < 0.05.
The mean gestational age was 39.6 +/- 2.6 and 38.2 +/- 2.9 weeks for the study and comparison groups, respectively. There were no differences between the groups in Bishop score, duration of the first stage of labor, maximum dose of oxytocin, indications for cesarean delivery, puerperal morbidity, birthweight, Apgar scores or NICU admissions. Sixty-four percent (57 of 89) of study women delivered vaginally compared with 82% (50 of 61) of women in the comparison group (P < 0.03). The data were analyzed separately for those women undergoing cervical ripening with PGE2 gel only. No differences were observed between the groups in any of the categories mentioned above.
Cervical ripening appears to be safe and effective in women with previous low transverse cesarean deliveries undergoing induction of labor with an unfavorable cervix.
评估既往有剖宫产史的孕妇在引产时进行引产前置宫颈成熟的安全性和有效性。
对既往有低位横切口剖宫产史且在引产前行宫颈成熟的孕妇进行回顾性研究(n = 89)。选取同期进行宫颈成熟及引产的无剖宫产史经产妇作为对照组(n = 61)。采用前列腺素E2(PGE2)凝胶或渗透扩张器或两者联合进行宫颈成熟。按照美国妇产科医师学会的指南使用缩宫素引产。根据情况使用非配对t检验或卡方检验分析结局数据。P < 0.05为有统计学意义。
研究组和对照组的平均孕周分别为39.6±2.6周和38.2±2.9周。两组在 Bishop评分、第一产程时长、缩宫素最大剂量、剖宫产指征、产褥期发病率、出生体重、阿氏评分或新生儿重症监护病房收治率方面无差异。研究组64%(89例中的57例)经阴道分娩,而对照组为82%(61例中的50例)(P < 0.03)。仅对使用PGE2凝胶进行宫颈成熟的女性的数据进行单独分析。上述任何类别中两组之间均未观察到差异。
对于既往有低位横切口剖宫产史且宫颈条件不佳的孕妇,宫颈成熟在引产时似乎是安全有效的。